These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 33650642

  • 21. Primary CNS lymphoma.
    Batchelor T, Loeffler JS.
    J Clin Oncol; 2006 Mar 10; 24(8):1281-8. PubMed ID: 16525183
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma.
    Kaulen LD, Galluzzo D, Hui P, Barbiero F, Karschnia P, Huttner A, Fulbright R, Baehring JM.
    J Neurooncol; 2019 Aug 10; 144(1):107-115. PubMed ID: 31190317
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Management of elderly patients with primary central nervous system lymphoma.
    Daras M, DeAngelis LM.
    Curr Neurol Neurosci Rep; 2013 May 10; 13(5):344. PubMed ID: 23564069
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
    Hatzl S, Posch F, Deutsch A, Beham-Schmid C, Stöger H, Greinix H, Pichler M, Neumeister P, Prochazka KT.
    Hematol Oncol; 2020 Aug 10; 38(3):277-283. PubMed ID: 32101329
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Primary Central Nervous System Lymphoma: Evolving Biologic Insights and Recent Therapeutic Advances.
    Chihara D, Dunleavy K.
    Clin Lymphoma Myeloma Leuk; 2021 Feb 10; 21(2):73-79. PubMed ID: 33288483
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical characteristics and prognosis of 49 newly diagnosed primary central nervous system diffuse large B-cell lymphoma].
    Song J, Liu H, Shen HL, Yue LZ, Yang XJ, Song WJ, Sun CY, Yu SZ, Ding K, Wang YH, Li LJ, Yu H, Shao YY, Wang CM, Yue SY, Fu R.
    Zhonghua Xue Ye Xue Za Zhi; 2021 Nov 14; 42(11):917-922. PubMed ID: 35045653
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.